The Use of Meta-Analysis in Cost-Effectiveness Analysis Sanjay SaintDavid L. VeenstraSean D. Sullivan Current Opinion 25 November 2012 Pages: 1 - 8
Willingness to Pay as a Measure of Health Benefits Mohan V. BalaJosephine A. MauskopfLisa L. Wood Leading Article 25 November 2012 Pages: 9 - 18
Evaluating Health-Related Quality-of-Life Outcomes in Patients with Congestive Heart Failure Nancy LeidyAnne M. RentzTeresa M. Zyczynski Review Article 25 November 2012 Pages: 19 - 46
Pharmacoeconomics of Lipid-Lowering Agents for Primary and Secondary Prevention of Coronary Artery Disease Joel HayWinnie M. YuTalat Ashraf Review Article 25 November 2012 Pages: 47 - 74
Cost-Benefit Analysis of Haemophilus influenzae Type b Vaccination in Children in Spain F. Javier JiménezPilar Guallar-CastillónEliseo Guallar Original Research Article 25 November 2012 Pages: 75 - 83
Cost Analysis of 2 Empiric Antibacterial Regimens Containing Glycopeptides for the Treatment of Febrile Neutropenia in Patients with Acute Leukaemia Giampaolo BucaneveFrancesco MenichettiAlbano Del Favero Original Research Article 25 November 2012 Pages: 85 - 95
Economic Evaluation of Antibacterials in the Treatment of Acute Sinusitis Claudine LaurierJean LachaineMurray Ducharme Original Research Article 25 November 2012 Pages: 97 - 113